T2 Biosystems, Inc. Contracts & Agreements
125 Contracts & Agreements
- Business Finance (38 contracts)
- Business Operations (22)
- Human Resources (38)
- Intellectual Property (1)
- Real Estate (10)
- Uncategorized (16)
- Securities Purchase Agreement, dated February 15, 2024 by and between the Company and the Lenders party thereto (Filed With SEC on February 15, 2024)
- T2 Biosystems, Inc. 2014 Incentive Award Plan, as amended and restated (Filed With SEC on November 15, 2023)
- 2014 Employee Stock Purchase Plan, as amended and restated (Filed With SEC on November 15, 2023)
- Amendment No. 9 to Term Loan Agreement, dated October 18, 2023, between T2 Biosystems, Inc. and CRG Servicing LLC (Filed With SEC on November 15, 2023)
- Amendment of Solicitation/Modification of Contract, dated as of May 1, 2023 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 22, 2023)
- Waiver and Consent to Term Loan Agreement with CRG Servicing LLC, dated May 19, 2023 (Filed With SEC on May 22, 2023)
- Underwriting Agreement, dated February 14, 2023, between T2 Biosystems, Inc. and Craig-Hallum Capital Group, LLC, as representatives of the several underwriters named therein (Filed With SEC on February 16, 2023)
- Form of Pre-funded Warrant (Filed With SEC on February 16, 2023)
- Form of Warrant (Filed With SEC on February 16, 2023)
- Amendment of Solicitation/Modification of Contract, dated as of September 29, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the... (Filed With SEC on November 14, 2022)
- Amendment No. 8 to Term Loan Agreement, dated November 10, 2022, between T2 Biosystems, Inc. and CRG Servicing LLC (Filed With SEC on November 14, 2022)
- Form of Warrant (Filed With SEC on August 16, 2022)
- Securities Purchase Agreement, dated as of August 15, 2022 (Filed With SEC on August 16, 2022)
- Amendment of Solicitation/Modification of Contract, dated as of July 26, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on August 16, 2022)
- Registration Rights Agreement, dated as of August 15, 2022 (Filed With SEC on August 16, 2022)
- Amendment of Solicitation/Modification of Contract, dated as of March 31, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 12, 2022)
- Amendment of Solicitation/Modification of Contract, dated as of April 22, 2022 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 12, 2022)
- Description of Securities (Filed With SEC on March 23, 2022)
- Non-Employee Director Compensation Program, effective as of March 21, 2022 (Filed With SEC on March 23, 2022)
- T2 BIOSYSTEMS, INC. INDUCEMENT AWARD PLAN (as amended and restated effective December 17, 2021) ARTICLE 1. PURPOSE (Filed With SEC on March 23, 2022)
- OFFER OF EMPLOYMENT (Filed With SEC on March 23, 2022)
- AMENDMENT No. 7 TO TERM LOAN AGREEMENT (Filed With SEC on March 23, 2022)
- Lease, dated September 3, 2021, by and between T2 Biosystems, Inc. and Farley White Concord Road, LLC (Filed With SEC on November 4, 2021)
- Amendment of Solicitation/Modification of Contract, dated as of September 30, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the... (Filed With SEC on November 4, 2021)
- Amendment of Solicitation/Modification of Contract, dated as of October 25, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on November 4, 2021)
- T2 Biosystems, Inc. 2014 Incentive Award Plan, as amended and restated (Filed With SEC on June 28, 2021)
- Amendment of Solicitation/Modification of Contract, dated as of April 30, 2021 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on May 13, 2021)
- Non-Employee Director Compensation Program, effective as of April 27, 2021 (Filed With SEC on May 13, 2021)
- Description of Securities (Filed With SEC on March 31, 2021)
- Non-Employee Director Compensation Program, effective as of February 24, 2021 (Filed With SEC on March 31, 2021)
- Amendment No. 6 to Term Loan Agreement, dated January 25, 2021, between T2 Biosystems, Inc. and CRG Servicing LLC (Filed With SEC on March 31, 2021)
- Employment Offer Letter, dated as of December 31, 2020, by and between the Company and Dr. Aparna Ahuja (Filed With SEC on March 31, 2021)
- Change of Control Severance Agreement, dated December 31 ,2020, by and between the Company and Dr. Aparna Ahuja (Filed With SEC on March 31, 2021)
- Amendment of Solicitation/Modification of Contract, dated as of September 30, 2020 by and between the Company and Biomedical Advanced Research and Development Authority of the... (Filed With SEC on November 5, 2020)
- Sixth Amendment to Lease by and between the Company and LS King Hartwell Innovation Campus LLC, dated as of October 19, 2020 (Filed With SEC on November 5, 2020)
- First Amendment to Lease by and between the Company and LS King Hartwell Innovation Campus LLC, dated as of October 19, 2020 (Filed With SEC on November 5, 2020)
- Amendment No. 5 to Commercial Lease between Columbus Day Realty, Inc. and the Company, dated as of October 20, 2020 (Filed With SEC on November 5, 2020)
- Amendment of Solicitation/Modification of Contract, dated as of July 6, 2020 by and between the Company and Biomedical Advanced Research and Development Authority of the U.S.... (Filed With SEC on August 12, 2020)
- Non-Employee Director Compensation Program, effective as of June 14, 2020 (Filed With SEC on August 12, 2020)
- 2014 Employee Stock Purchase Plan, as amended and restated effective August 6, 2020 (Filed With SEC on August 12, 2020)
- Amendment No. 2 to Equity Distribution Agreement dated as of April 8, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on April 8, 2020)
- Offer Letter, dated as of March 11, 2019, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)
- Promotion Letter, dated as of January 3, 2020, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)
- Change in Control Severance Agreement, dated as of March 11, 2019, by and between the Company and Anthony Pare (Filed With SEC on March 16, 2020)
- Amendment No. 1 to Equity Distribution Agreement dated as of March 9, 2020 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on March 10, 2020)
- Employment Agreement, dated as of January 8, 2020, by and between the Company and John Sperzel (Filed With SEC on January 9, 2020)
- T2 Biosystems, Inc. Inducement Award Plan, as amended, and forms of award agreements thereunder (Filed With SEC on January 9, 2020)
- Amendment No. 5 to Term Loan Agreement, dated as of September 10, 2019, by and among the Company, CRG Servicing LLC and the lenders listed on the signature pages thereto 31.1*... (Filed With SEC on November 18, 2019)
- Registration Rights Agreement dated as of July 29, 2019 by and between T2 Biosystems, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on July 30, 2019)
- Equity Distribution Agreement dated as of July 30, 2019 by and between T2 Biosystems, Inc. and Canaccord Genuity LLC (Filed With SEC on July 30, 2019)
- Purchase Agreement dated as of July 29, 2019 by and between T2 Biosystems, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on July 30, 2019)
- Second Amendment to Employment Agreement, dated July 30, 2019, between the Company and John McDonough (Filed With SEC on July 30, 2019)
- GE Catalog Supply Agreement OEM Retail, dated March 15, 2019, by and between the Company and GE Healthcare Bio-Sciences Corp (Filed With SEC on May 10, 2019)
- Non-Employee Director Compensation Program, effective as of February 21, 2019 (Filed With SEC on May 10, 2019)
- Non-Employee Director Compensation Program, effective as of February 21, 2019 (Filed With SEC on March 14, 2019)
- T2 Biosystems, Inc. Inducement Award Plan (as amended and restated, effective February 21, 2019) and form of option agreement, restricted stock agreement, and restricted stock... (Filed With SEC on March 14, 2019)
- Employment Offer Letter, dated as of October 29, 2014, by and between the Company and Michael Gibbs (Filed With SEC on March 14, 2019)
- Change of Control Severance Agreement, dated October 29, 2014, by and between the Company and Michael Gibbs (Filed With SEC on March 14, 2019)
- Amendment to Change of Control Severance Agreement, by and between the Company and Michael Gibbs, dated June 6, 2017 (Filed With SEC on March 14, 2019)
- Separation Agreement, dated January 30, 2018, by and between the Company and Darlene Deptula-Hicks (Filed With SEC on March 14, 2019)
- Separation Agreement, dated March 13, 2018, by and between the Company and Joanne Spadoro (Filed With SEC on March 14, 2019)
- Fifth Amendment to Lease, dated December 6, 2018 (Filed With SEC on December 12, 2018)
- Fourth Amendment to Lease, dated August 31, 2018 (Filed With SEC on September 7, 2018)
- Underwriting Agreement, dated as of May 30, 2018, by and between T2 Biosystems, Inc. and Leerink Partners LLC, as representative of the several underwriters named therein (Filed With SEC on June 4, 2018)
- Third Amendment to Supply Agreement, dated May 16, 2018 (Filed With SEC on May 17, 2018)
- Non-Employee Director Compensation Program, effective as of December 26, 2017 (Filed With SEC on May 8, 2018)
- Amended and Restated 2014 Incentive Award Plan and form of option agreements thereunder (Filed With SEC on March 19, 2018)
- Co-Development, Collaboration and Co-Marketing Agreement, dated November 1, 2016, by and between the Company and Allergan Sales, LLC (Filed With SEC on March 19, 2018)
- T2 Biosystems, Inc. Inducement Award Plan and form of stock option agreement, form of restricted stock agreement and form of restricted stock unit agreement thereunder (Filed With SEC on March 7, 2018)
- Second Amendment to Supply Agreement, dated December 22, 2017 (Filed With SEC on December 27, 2017)
- Lease Indenture Agreement, dated September 21, 2017, between 91 Hartwell Ave. Trust and the Company, relating to office space located for property at 91 Harwell Avenue, Lexington,... (Filed With SEC on November 3, 2017)
- Underwriting Agreement, dated as of September 15, 2017, by and among T2 Biosystems, Inc. and Canaccord Genuity Inc. and Cantor Fitzgerald & Co., as representatives of the several... (Filed With SEC on September 19, 2017)
- Amendment to Supply Agreement, dated August 29, 2017 (Filed With SEC on September 5, 2017)
- AMENDMENT TO CO-DEVELOPMENT, COLLABORATION AND CO-MARKETING AGREEMENT (Filed With SEC on August 4, 2017)
- OFFER OF EMPLOYMENT (Filed With SEC on May 8, 2017)
- T2 BIOSYSTEMS, INC. Change of Control Severance Agreement (Filed With SEC on May 8, 2017)
- AMENDMENT NO. 1 TO TERM LOAN AGREEMENT (Filed With SEC on May 8, 2017)
- T2 BIOSYSTEMS, Inc. Non-Employee DIRECTOR COMPENSATION PROGRAM (effective as of February 9, 2017) (Filed With SEC on May 8, 2017)
- CO-DEVELOPMENT, COLLABORATION AND CO-MARKETING AGREEMENT (Filed With SEC on March 15, 2017)
- FOURTH AMENDMENT TO LEASE (Filed With SEC on March 3, 2017)
- OFFER OF EMPLOYMENT (Filed With SEC on November 8, 2016)
- T2 BIOSYSTEMS, INC. Change of Control Severance Agreement (Filed With SEC on November 8, 2016)
- STOCK PURCHASE AGREEMENT (Filed With SEC on September 22, 2016)
- VOTING AND STANDSTILL AGREEMENT (Filed With SEC on September 22, 2016)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on September 22, 2016)
- OFFER OF EMPLOYMENT (Filed With SEC on August 8, 2016)
- T2 BIOSYSTEMS, INC. Change of Control Severance Agreement (Filed With SEC on August 8, 2016)
- T2 BIOSYSTEMS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 9, 2016)
- T2 BIOSYSTEMS, INC. CHANGE OF CONTROL SEVERANCE AGREEMENT (Filed With SEC on May 9, 2016)
- OFFER OF EMPLOYMENT (Filed With SEC on March 9, 2016)
- Second Amendment to Loan and Security Agreement (Filed With SEC on March 9, 2016)
- (Signature Page Follows) (Filed With SEC on March 9, 2016)
- OFFER OF EMPLOYMENT (Filed With SEC on March 9, 2016)
- T2 Biosystems, Inc. Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on December 9, 2015)
- T2 BIOSYSTEMS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (as amended effective July 1, 2015) (Filed With SEC on August 5, 2015)
- THIRD AMENDMENT TO LEASE (Filed With SEC on May 29, 2015)
- FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 29, 2015)
- CO-DEVELOPMENT PARTNERSHIP AGREEMENT (Filed With SEC on March 4, 2015)
- SUPPLY AGREEMENT (Filed With SEC on January 21, 2015)
- SUPPLY AGREEMENT (Filed With SEC on October 17, 2014)
- T2 Biosystems, Inc. Common Stock, par value $0.001 per share Underwriting Agreement (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT March 22, 2013 (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. 2014 INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on July 28, 2014)
- FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. (Filed With SEC on July 28, 2014)
- BIOPLEX SYSTEMS, INC. 343 Otis Street West Newton, MA 02465 (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 28, 2014)
- T2 BIOSYSTEMS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT March 22, 2013 (Filed With SEC on July 2, 2014)
- T2 BIOSYSTEMS, INC. AMENDED AND RESTATED 2006 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (as amended July 1, 2014) (Filed With SEC on July 2, 2014)
- OFFER OF EMPLOYMENT (Filed With SEC on July 2, 2014)
- OFFER OF EMPLOYMENT NAME: Sarah Kalil (Filed With SEC on July 2, 2014)
- OFFER OF EMPLOYMENT (Filed With SEC on July 2, 2014)
- One Memorial Drive Cambridge, MA 02142 (Filed With SEC on July 2, 2014)
- BIOPLEX SYSTEMS, INC. 343 Otis Street West Newton, MA 02465 (Filed With SEC on July 2, 2014)
- BIOPLEX SYSTEMS, INC. 343 Otis Street West Newton, MA 02465 (Filed With SEC on July 2, 2014)
- SALES AGREEMENT (Filed With SEC on July 2, 2014)
- THE GENERAL HOSPITAL CORPORATION EXCLUSIVE LICENSE AGREEMENT MGH Agreement No.: 2006A21314 MGH Case Nos.: 1864 and 2745 (Filed With SEC on July 2, 2014)
- SECURITY AGREEMENT (Filed With SEC on July 2, 2014)
- LOAN AND SECURITY AGREEMENT (Filed With SEC on July 2, 2014)
- COMMERCIAL LEASE (Filed With SEC on July 2, 2014)
- 101 HARTWELL AVENUE LEXINGTON, MASSACHUSETTS LEASE SUMMARY SHEET (Filed With SEC on July 2, 2014)